1 completed, 1 recruiting, 1 unknown, 1 withdrawn. 3 Phase 2, 1 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 1, Recruiting 1, Withdrawn 1 |
| Not applicable | 1 | Unknown 1 |
| Phase 1 | 1 | Withdrawn 1 |
Follow Sinonasal Cancer: new trials by email Literature Review of Sinonasal Cancer trials Research Report on Sinonasal Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Front Line Pembrolizumab and Valemetostat in PD-L1 Positive, HPV-Negative Recurrent/Metastatic Squamous Cell Carcinoma (SCC) of the Head and Neck: The PANTHERAS pembrolizumab, valemetostat - Sinonasal Cancer, Squamous Non-small Cell Lung Cancer | Phase 1 / Phase 2 | Withdrawn | National Cancer Institute (NCI) | 2025-07-09 | 2025-07-10 | |
| Toripalimab With Chemotherapy for Sinus Cancer Toripalimab, Carboplatin, Docetaxel - Sinonasal Cancer, Paranasal Sinus Neoplasms | Phase 2 | Recruiting | Dana-Farber Cancer Institute | 20 | 2025-06-17 | 2026-08-31 |
| Radiotherapy of Head and Neck Cancer Using an Intraoral Stent Intraoral stent, No intraoral stent - Oral Cavity Cancer, Sinonasal Cancer | Phase 2 | Completed | Oslo University Hospital | 220 | 2020-01-01 | 2025-07-09 |
| Cell-free Tumor DNA in Head and Neck Cancer Patients Liquid biopsy - Head and Neck Cancer, Head and Neck Neoplasms | Not applicable | Unknown | Christian von Buchwald | 500 | 2017-02-01 | 2021-09-21 |
Head and Neck Neoplasms (4) · Mouth Neoplasms (2) · Squamous Cell Carcinoma of Head and Neck (2) · Carcinoma, Squamous Cell (1) · Hypopharyngeal Neoplasms (1) · Laryngeal Neoplasms (1) · Lung Neoplasms (1) · Nasopharyngeal Carcinoma (1) · Nasopharyngeal Neoplasms (1) · Oropharyngeal Neoplasms (1) · Paranasal Sinus Neoplasms (1) · Salivary Gland Neoplasms (1) · Sinonasal undifferentiated carcinoma (1) · Thyroid Neoplasms (1)
Neoplasms (4) · Neoplasms by Site (4) · Carcinoma (3) · Neoplasms by Histologic Type (3) · Neoplasms, Glandular and Epithelial (3) · Respiratory Tract Diseases (3) · Respiratory Tract Neoplasms (3) · Carcinoma, Squamous Cell (2) · Mouth Diseases (2) · Otorhinolaryngologic Diseases (2) · Otorhinolaryngologic Neoplasms (2) · Stomatognathic Diseases (2) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Laryngeal Diseases (1)
Carboplatin (1) · Cisplatin (1) · Docetaxel (1) · Liquid Biopsy (1) · Radiotherapy (1) · pembrolizumab (1) · toripalimab (1)
Christian von Buchwald (1) · Dana-Farber Cancer Institute (1) · National Cancer Institute (NCI) (1) · Oslo University Hospital (1)
United States (2) · Denmark (1) · Norway (1)
Christian Von Buchwald, MD, DMSc (1) · Einar Dale, MD PhD (1) · Kartik Sehgal, MD (1) · Vassiliki Saloura, M.D. (1)